Variant report

Variant	esv3692764
Chromosome Location	chr2:234647478-234658623
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:234653876-234654428	HepG2	liver:	n/a	n/a
2	ATF3	chr2:234653988-234654486	A549	lung:	n/a	n/a
3	BCL3	chr2:234653885-234654544	A549	lung:	n/a	n/a
4	BCL3	chr2:234653958-234654499	A549	lung:	n/a	n/a
5	BHLHE40	chr2:234654058-234654451	HepG2	liver:	n/a	n/a
6	CEBPB	chr2:234656934-234657289	HepG2	liver:	n/a	chr2:234657082-234657093 chr2:234657082-234657093 chr2:234657104-234657115
7	CEBPB	chr2:234656935-234657273	A549	lung:	n/a	chr2:234657082-234657093 chr2:234657082-234657093 chr2:234657104-234657115
8	CEBPB	chr2:234657008-234657264	IMR90	lung:	n/a	chr2:234657082-234657093 chr2:234657082-234657093 chr2:234657104-234657115
9	CEBPB	chr2:234653908-234654385	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
10	CEBPB	chr2:234653902-234654598	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
11	CEBPB	chr2:234653961-234654410	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
12	CEBPB	chr2:234653943-234654318	A549	lung:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
13	CEBPB	chr2:234654020-234654389	A549	lung:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
14	CEBPB	chr2:234653892-234654497	A549	lung:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
15	CEBPB	chr2:234653979-234654335	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
16	CEBPD	chr2:234654049-234654478	HepG2	liver:	n/a	n/a
17	CHD2	chr2:234654164-234654273	HepG2	liver:	n/a	n/a
18	CREB1	chr2:234654194-234654509	A549	lung:	n/a	n/a
19	CREB1	chr2:234653968-234654547	HepG2	liver:	n/a	n/a
20	CREB1	chr2:234653888-234654608	HepG2	liver:	n/a	n/a
21	CREB1	chr2:234654062-234654459	A549	lung:	n/a	n/a
22	CTCF	chr2:234651956-234652041	Kidney_OC	kidney:	n/a	n/a
23	CTCF	chr2:234651938-234652009	GM20000	blood:	n/a	n/a
24	EP300	chr2:234654030-234654453	HepG2	liver:	n/a	chr2:234654068-234654082
25	EP300	chr2:234653933-234654548	HepG2	liver:	n/a	chr2:234654068-234654082
26	EP300	chr2:234653700-234654700	A549	lung:	n/a	chr2:234654068-234654082 chr2:234653862-234653871
27	EP300	chr2:234653868-234654574	HepG2	liver:	n/a	chr2:234654068-234654082
28	EP300	chr2:234653810-234654542	A549	lung:	n/a	chr2:234654068-234654082 chr2:234653862-234653871
29	FOSL2	chr2:234654000-234654628	HepG2	liver:	n/a	n/a
30	FOSL2	chr2:234653946-234654485	HepG2	liver:	n/a	n/a
31	FOSL2	chr2:234654004-234654404	A549	lung:	n/a	n/a
32	FOSL2	chr2:234653860-234654613	A549	lung:	n/a	n/a
33	FOXA1	chr2:234653527-234654585	HepG2	liver:	n/a	n/a
34	FOXA1	chr2:234653871-234654608	HepG2	liver:	n/a	n/a
35	FOXA1	chr2:234653906-234654589	HepG2	liver:	n/a	n/a
36	FOXA1	chr2:234653830-234654570	HepG2	liver:	n/a	n/a
37	FOXA2	chr2:234653696-234654749	HepG2	liver:	n/a	n/a
38	FOXA2	chr2:234653649-234654629	A549	lung:	n/a	n/a
39	FOXA2	chr2:234653954-234654644	A549	lung:	n/a	n/a
40	FOXA2	chr2:234653884-234654483	HepG2	liver:	n/a	n/a
41	GATA3	chr2:234653893-234654633	A549	lung:	n/a	n/a
42	GATA3	chr2:234653885-234654644	A549	lung:	n/a	n/a
43	HDAC2	chr2:234653853-234654551	HepG2	liver:	n/a	n/a
44	HDAC2	chr2:234653902-234654531	HepG2	liver:	n/a	n/a
45	HEY1	chr2:234652495-234652743	K562	blood:	n/a	n/a
46	HNF4A	chr2:234653992-234654483	HepG2	liver:	n/a	chr2:234654285-234654298 chr2:234654285-234654300 chr2:234654281-234654303 chr2:234654233-234654248 chr2:234654285-234654298
47	HNF4A	chr2:234654029-234654486	HepG2	liver:	n/a	chr2:234654285-234654298 chr2:234654285-234654300 chr2:234654281-234654303 chr2:234654233-234654248 chr2:234654285-234654298
48	HNF4A	chr2:234653907-234654493	HepG2	liver:	n/a	chr2:234654285-234654298 chr2:234654285-234654300 chr2:234654281-234654303 chr2:234654233-234654248 chr2:234654285-234654298
49	HNF4G	chr2:234653874-234654479	HepG2	liver:	n/a	chr2:234654285-234654298 chr2:234654285-234654300 chr2:234654281-234654303 chr2:234654285-234654298
50	HNF4G	chr2:234653857-234654583	HepG2	liver:	n/a	chr2:234654285-234654298 chr2:234654285-234654300 chr2:234654281-234654303 chr2:234654285-234654298

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:234649204-234649254	PFSK-1	brain:	n/a
2	chr2:234649204-234649254	PFSK-1	brain:	n/a
3	chr2:234650765-234650815	ovcar-3	ovarian:	n/a
4	chr2:234649204-234649254	PANC-1	pancreas:	n/a
5	chr2:234652681-234652731	ECC-1	luminal epithelium:	n/a
6	chr2:234652601-234652651	NHBE	bronchial:	n/a
7	chr2:234652681-234652731	BE2_C	brain:	n/a
8	chr2:234649204-234649254	HMEC	breast:	n/a
9	chr2:234652601-234652651	H1-hESC	embryonic stem cell:	embryo
10	chr2:234651850-234651900	PFSK-1	brain:	n/a
11	chr2:234651850-234651900	H1-hESC	embryonic stem cell:	embryo
12	chr2:234652363-234652413	NHBE	bronchial:	n/a
13	chr2:234653891-234653941	HCT-116	colon:	n/a
14	chr2:234652466-234652516	K562	blood:	n/a
15	chr2:234655709-234655759	HCT-116	colon:	n/a
16	chr2:234655709-234655759	ECC-1	luminal epithelium:	n/a
17	chr2:234652466-234652516	GM19239	blood:	n/a
18	chr2:234653891-234653941	U87	brain:	n/a
19	chr2:234655709-234655759	HAEpiC	amniotic membrane:	n/a
20	chr2:234652466-234652516	CMK	blood:	n/a
21	chr2:234652363-234652413	HCT-116	colon:	n/a
22	chr2:234652681-234652731	HCF	heart:	n/a
23	chr2:234652681-234652731	H1-hESC	embryonic stem cell:	embryo
24	chr2:234653891-234653941	HIPEpiC	eye:	n/a
25	chr2:234652669-234652719	ProgFib	skin:	n/a
26	chr2:234653891-234653941	LNCaP	prostate:	n/a
27	chr2:234650765-234650815	HCM	heart:	n/a
28	chr2:234651850-234651900	BJ	skin:	n/a
29	chr2:234652669-234652719	K562	blood:	n/a
30	chr2:234650765-234650815	BE2_C	brain:	n/a
31	chr2:234649204-234649254	SK-N-SH_RA	brain:	n/a
32	chr2:234652363-234652413	HRPEpiC	eye:	n/a
33	chr2:234652601-234652651	IMR90	lung:	fetal
34	chr2:234652363-234652413	A549	lung:	n/a
35	chr2:234651850-234651900	MCF-7	breast:	n/a
36	chr2:234652681-234652731	AG04450	lung:	fetal
37	chr2:234652681-234652731	Hela-S3	cervix:	n/a
38	chr2:234652681-234652731	NB4	blood:	n/a
39	chr2:234652669-234652719	ECC-1	luminal epithelium:	n/a
40	chr2:234649204-234649254	RPTEC	kidney:	n/a
41	chr2:234652601-234652651	Hela-S3	cervix:	n/a
42	chr2:234652466-234652516	NHBE	bronchial:	n/a
43	chr2:234652681-234652731	SK-N-SH_RA	brain:	n/a
44	chr2:234649204-234649254	HRE	kidney:	n/a
45	chr2:234652466-234652516	U87	brain:	n/a
46	chr2:234652601-234652651	HRE	kidney:	n/a
47	chr2:234655709-234655759	SAEC	small airway:	n/a
48	chr2:234652681-234652731	CMK	blood:	n/a
49	chr2:234652466-234652516	HEEpiC	esophagus:	n/a
50	chr2:234649204-234649254	HCM	heart:	n/a

No.	Distal block	Cell Line	Cell type
1	2:234543708-234558325..2:234649753-234657866	Hela-S3	cervix:
2	chr2:234650134..234652973-chr2:234653062..234655371,2	MCF-7	breast:
3	chr17:63274126..63274957-chr2:234657055..234657979,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-UGT1A1-2	chr2:234649334-234649521	NONHSAT077507
2	lnc-UGT1A1-2	chr2:234647598-234647701	NONHSAT077507
3	lnc-UGT1A1-2	chr2:234650166-234650603	NONHSAT077507

Variant related genes	Relation type
UGT1A2P	TF binding region
ENSG00000248705	TF binding region
ENSG00000248114	TF binding region
DNAJB3	TF binding region
UGT1A2P	CpG island
ENSG00000248705	CpG island
ENSG00000248114	CpG island
DNAJB3	CpG island
ENSG00000242515	chromatin interactions
ENSG00000227802	chromatin interactions
ENSG00000234143	chromatin interactions

Extended variants
information (count: 580 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:580 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs6431628	chr2:234647478-234647479	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs551176357	chr2:234647487-234647488	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs548510630	chr2:234647596-234647597	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs185032908	chr2:234647612-234647613	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
5	rs189887641	chr2:234647710-234647711	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs368529086	chr2:234647756-234647757	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs547420418	chr2:234647759-234647760	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs570890692	chr2:234647779-234647780	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs539919985	chr2:234647785-234647786	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs182453819	chr2:234647801-234647802	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs76713617	chr2:234647806-234647807	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs535426157	chr2:234647843-234647844	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs555664061	chr2:234647844-234647845	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs185605986	chr2:234647854-234647855	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs372926938	chr2:234647860-234647861	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs541301086	chr2:234647917-234647918	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs11691824	chr2:234647925-234647926	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs576910081	chr2:234647927-234647928	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs11691827	chr2:234647944-234647945	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs191477827	chr2:234648012-234648013	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs531347929	chr2:234648070-234648071	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs548179341	chr2:234648071-234648072	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs371985303	chr2:234648074-234648075	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs369218024	chr2:234648080-234648081	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs115541121	chr2:234648098-234648099	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs547322370	chr2:234648099-234648100	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs183243418	chr2:234648104-234648105	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs188701117	chr2:234648116-234648117	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs141853649	chr2:234648117-234648118	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs569787669	chr2:234648123-234648124	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs535486258	chr2:234648131-234648132	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs35203555	chr2:234648139-234648140	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs555327898	chr2:234648189-234648190	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs572450028	chr2:234648270-234648271	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs535320958	chr2:234648276-234648277	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs558118355	chr2:234648332-234648333	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs578128950	chr2:234648354-234648355	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs193084224	chr2:234648367-234648368	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs183557056	chr2:234648380-234648381	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs186719753	chr2:234648385-234648386	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs541880710	chr2:234648386-234648387	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs11695770	chr2:234648452-234648453	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs527239626	chr2:234648453-234648454	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs146148074	chr2:234648463-234648464	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs555368732	chr2:234648466-234648467	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs371090743	chr2:234648491-234648492	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs28900070	chr2:234648515-234648516	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs28900071	chr2:234648523-234648524	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs370697859	chr2:234648550-234648551	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs572345956	chr2:234648555-234648556	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cervical cancer	21062161	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Chordoma	18071362	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Cancer	22429812	CNVD
Bladder cancer	21909424	CNVD
Renal cell carcinoma	21668985	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
prenatal diagnosis	22389664	CNVD
Myelofibrosis	22110671	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Mental retardation	20152051	CNVD
Cancer	21183584	CNVD
Albright''s disease	22277900	CNVD
Brachydactyly-Mental Retardation Syndrome	22470819	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Colorectal cancer	19359472	CNVD
Autism	18414403	CNVD
Chronic myeloid leukemia	21384125	CNVD
Pancreatic cancer	17952125	CNVD
Congenital anomalies of the kidney and urinary tract	20605837	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:234620400-234659200	Weak transcription	Colonic Mucosa	Colon
2	chr2:234620600-234652200	Weak transcription	Esophagus	oesophagus
3	chr2:234626200-234649600	Weak transcription	Rectal Mucosa Donor 29	rectum
4	chr2:234626600-234668400	Weak transcription	NHEK	skin
5	chr2:234634600-234648400	Weak transcription	A549	lung
6	chr2:234645400-234648600	Enhancers	Liver	Liver
7	chr2:234646200-234648000	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
8	chr2:234646400-234648800	Bivalent Enhancer	HepG2	liver
9	chr2:234646400-234651000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
10	chr2:234646400-234666600	Weak transcription	Stomach Mucosa	stomach
11	chr2:234647000-234648000	Weak transcription	Duodenum Mucosa	Duodenum
12	chr2:234647000-234648400	Enhancers	Fetal Intestine Large	intestine
13	chr2:234647600-234647800	Enhancers	Gastric	stomach
14	chr2:234647800-234652200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr2:234647800-234655000	Weak transcription	Gastric	stomach
16	chr2:234648000-234648600	Enhancers	Duodenum Mucosa	Duodenum
17	chr2:234648000-234649800	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
18	chr2:234648400-234648600	Enhancers	A549	lung
19	chr2:234648600-234649200	Weak transcription	Duodenum Mucosa	Duodenum
20	chr2:234648600-234649200	Weak transcription	A549	lung
21	chr2:234648600-234650400	Weak transcription	Liver	Liver
22	chr2:234649600-234649800	Enhancers	Rectal Mucosa Donor 29	rectum
23	chr2:234649800-234652200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
24	chr2:234649800-234658800	Weak transcription	Rectal Mucosa Donor 29	rectum
25	chr2:234650400-234652600	Genic enhancers	Liver	Liver
26	chr2:234651000-234652800	Strong transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
27	chr2:234652200-234652600	ZNF genes & repeats	iPS DF 6.9 Cell Line	embryonic stem cell
28	chr2:234652200-234652600	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr2:234652200-234652600	ZNF genes & repeats	Esophagus	oesophagus
30	chr2:234652200-234652800	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
31	chr2:234652400-234652600	Flanking Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
32	chr2:234652600-234654400	Enhancers	Liver	Liver
33	chr2:234652600-234654600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr2:234652800-234658200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
35	chr2:234652800-234659200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
36	chr2:234653200-234654400	Enhancers	HepG2	liver
37	chr2:234653200-234655600	Enhancers	Fetal Intestine Small	intestine
38	chr2:234653400-234653800	Enhancers	A549	lung
39	chr2:234653800-234654200	Active TSS	A549	lung
40	chr2:234654200-234654800	Enhancers	Small Intestine	intestine
41	chr2:234654200-234655000	Enhancers	A549	lung
42	chr2:234654200-234655400	Enhancers	Duodenum Mucosa	Duodenum
43	chr2:234654200-234655400	Enhancers	Fetal Intestine Large	intestine
44	chr2:234654400-234654600	Flanking Active TSS	HepG2	liver
45	chr2:234654400-234656000	Flanking Active TSS	Liver	Liver
46	chr2:234654600-234655800	Bivalent Enhancer	HepG2	liver
47	chr2:234655000-234655200	Flanking Active TSS	A549	lung
48	chr2:234655000-234655600	Enhancers	Gastric	stomach
49	chr2:234655200-234655400	Enhancers	A549	lung
50	chr2:234655400-234655600	Flanking Active TSS	A549	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links